Company: HURA
Filing Date: 2025-05-23
Form Type: 424B3
Source: 0001193125-25-125499
Chunk: 143

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-23
Form: 424B3
Chunk 143
---
 it in order to have committed a violation;                                                                                  |

| • |     | analogous state and foreign laws and regulations relating to health care fraud and abuse, such as state                                                                                                        
 anti-kickback and false claims laws, that may apply to sales or marketing arrangements and claims involving health care items or services reimbursed by non-governmental third-party payors, including private 
 insurers;                                                                                                                                                                                                      |

| • |     | the FCPA and other anti-corruption laws and regulations pertaining to TuHURA’s financial relationships and 
 interactions with foreign government officials;                                                            |

| • |     | the U.S. federal physician payment transparency requirements, sometimes referred to as the “Sunshine                                                                                                                                                  
 Act,” which requires manufacturers of drugs, devices, biologics and medical supplies that are reimbursable under Medicare, Medicaid, or the Children’s Health Insurance Program to report to the Centers for Medicare & Medicaid                      
 Services (“CMS”), information related to physician payments and other transfers of value to physicians (defined to include doctors, dentists, optometrists, podiatrists and chiropractors) and teaching hospitals as well as the ownership and        
 investment interests of physicians and their immediate family members. Beginning in 2022, applicable manufacturers are required to report such information regarding its relationships with physician assistants, nurse practitioners, clinical nurse 
 specialists, certified registered nurse anesthetists and certified nurse midwives during the previous year;                                                                                                                                           |

| • |     | analogous state and foreign laws that require pharmaceutical companies to track, report and disclose to the                                                                                                                                               
 government and/or the public information related to payments, gifts, and other transfers of value or remuneration to physicians and other health care providers, marketing activities or expenditures, or product pricing or transparency information, or 
 that require pharmaceutical companies to implement compliance programs that meet certain standards or to restrict or limit interactions between pharmaceutical manufacturers and members of the health care industry;                                     |

| • |     | the U.S. federal laws that require pharmaceutical manufacturers to report certain calculated product prices to                                                                  
 the government or provide certain discounts or rebates to government authorities or private entities, often as a condition of reimbursement under federal health care programs; |

| • |     | HIPAA, which imposes obligations on certain covered entity health care providers, health plans, and health care                                                                                                                                         
 clearinghouses and their business associates that perform certain services involving the use or disclosure of individually identifiable health information as well as their covered subcontractors, including mandatory contractual terms, with respect 
 to safeguarding the privacy, security and transmission